Results 21 to 30 of about 8,267 (258)

Ketogenic diets therapy in the management of epileptic spasms syndrome. [PDF]

open access: yesFront Pediatr
Infantile Epileptic Spasm Syndrome (IESS) is a group of infantile spasm syndromes of various etiologies that typically present in early infancy, predispose to refractory epilepsy, and leave intellectual disability. Ketogenic diet therapy (KDT) is a non-pharmacologic treatment modality for medically refractory IESS.
Wang M, Zhao F, Sun L, Yu Y, Zhang H.
europepmc   +4 more sources

Epileptic Encephalopathies, CDKL5 Mutations, and Infantile Spasms

open access: yesPediatric Neurology Briefs, 2012
Researchers at the Mayo Clinic, Rochester, MN performed retrospective chart reviews of 6 children with epilepsy and CDKL5 mutations.
J Gordon Millichap
doaj   +3 more sources

Epileptic spasms in infants: can video-EEG reveal the disease’s etiology? A retrospective study and literature review

open access: yesFrontiers in Neurology, 2023
ObjectiveEpileptic spasms are a type of seizure defined as a sudden flexion or extension predominantly of axial and/or truncal limb muscles that occur with a noticeable periodicity. Routine electroencephalogram supports the diagnosis of epileptic spasms,
Raffaele Falsaperla   +8 more
doaj   +1 more source

Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids

open access: yesEBioMedicine, 2022
Summary: Background: Epileptic (previously infantile) spasms is the most common epileptic encephalopathy occurring during infancy and is frequently associated with abnormal neurodevelopmental outcomes.
Jingya Yan   +22 more
doaj   +1 more source

Distinct T Cell Dysregulation Reflects Disease Severity and Progression in Infantile Epileptic Spasms Syndrome and Lennox-Gastaut Syndrome. [PDF]

open access: goldImmune Netw
Chang L   +11 more
europepmc   +2 more sources

Epileptic spasms in congenital disorders of glycosylation [PDF]

open access: yesEpileptic Disorders, 2017
AbstractAim. Congenital disorders of glycosylation (CDG) are a group of rare metabolic diseases, characterized by impaired glycosylation. Multisystemic involvement is common and neurological impairment is notably severe and disabling, concerning the central and peripheral nervous system. Epilepsy is frequent, but detailed electroclinical description is
Pereira, AG   +7 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy